Authors: FIROOZ A ALIMOHAMMADIAN MH KHAMESIPOUR A DOWLATI Y

Citation: A. Firooz et al., CLINICAL-TRIAL OF THE SAFETY AND IMMUNOGENICITY OF 3 DOSES OF A LEISHMANIA VACCINE, Journal of investigative dermatology, 110(4), 1998, pp. 671-671

Authors: AJDARY S HOSSEINI MH ALIMOHAMMADIAN MH

Citation: S. Ajdary et al., RECOMBINANT INTERLEUKIN-1 PROMOTES LEISHMANIASIS IN SUSCEPTIBLE MICE, Microbiology and immunology, 41(3), 1997, pp. 281-283

Authors: RAFATI S COUTYJOUVE S ALIMOHAMMADIAN MH LOUIS JA

Citation: S. Rafati et al., BIOCHEMICAL-ANALYSIS AND IMMUNOGENICITY OF LEISHMANIA-MAJOR AMASTIGOTE FRACTIONS IN CUTANEOUS LEISHMANIASIS, Clinical and experimental immunology, 110(2), 1997, pp. 203-211

Authors: BAHAR K DOWLATI Y SHIDANI B ALIMOHAMMADIAN MH KHAMESIPOUR A EHSASI S HASHEMIFESHARKI R ALEAGHA S MODABBER F

Citation: K. Bahar et al., COMPARATIVE SAFETY AND IMMUNOGENICITY TRIAL OF 2 KILLED LEISHMANIA-MAJOR VACCINES WITH OR WITHOUT BCG IN HUMAN VOLUNTEERS, Clinics in dermatology, 14(5), 1996, pp. 489-495

Authors: KHARAZMI A ALIMOHAMMADIAN MH

Citation: A. Kharazmi et Mh. Alimohammadian, COMPARISON BETWEEN LEISHMANINS - A REPLY, Transactions of the Royal Society of Tropical Medicine and Hygiene, 88(2), 1994, pp. 255-255

Authors: ALIMOHAMMADIAN MH KIVANJAH M PAK F GAZNAVIA A KHARAZMI A

Citation: Mh. Alimohammadian et al., EVALUATION OF THE EFFICACY OF IRAN LEISHMANIN AND COMPARISON WITH LEISHMANINS FROM WELLCOME (UK) AND ROMA (ITALY) IN CURED CUTANEOUS LEISHMANIASIS PATIENTS, Transactions of the Royal Society of Tropical Medicine and Hygiene, 87(5), 1993, pp. 550-550